Lenalidomide - Celgene Corporation
At a glance
- Drug Originator Celgene Corporation
- Drug Licenced by BeiGene; Knight Therapeutics
- Drug Class 2 ring heterocyclic compounds; Antineoplastics; Imides; Isoindoles; Piperidones; Small molecules
- Mechanism of Action Angiogenesis inhibitors; Apoptosis stimulants; Cell proliferation inhibitors; Immunomodulators; Interleukin 6 inhibitors; Tumour necrosis factor alpha inhibitors; Vascular endothelial growth factors inhibitors
- USA Patent Applicants BRISTOL MYERS SQUIBB
- USA Patents 68
- NDAs 1
- International Patents 378
- Patent Applications 633
Table of Contents

Disclaimer